Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study

A prospective cohort study was conducted to evaluate long-term safety of tedizolid as suppressive antimicrobial treatment in patients with implant-associated bone and joint infection caused by multidrug-resistant gram-positive pathogens. Seventeen patients received tedizolid with a median duration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferry, Tristan, Conrad, Anne, Senneville, Eric, Roux, Sandrine, Dupieux-Chabert, Céline, Dinh, Aurélien, Lustig, Sébastien, Goutelle, Sylvain, Briot, Thomas, Pham, Truong-Thanh, Valour, Florent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320277/
https://www.ncbi.nlm.nih.gov/pubmed/34337099
http://dx.doi.org/10.1093/ofid/ofab351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320277/
https://www.ncbi.nlm.nih.gov/pubmed/34337099
http://dx.doi.org/10.1093/ofid/ofab351

Ejemplares similares